While there was improvement yet no difference between treatment group and placebo for the
FSFI domains except lubrication, which did improve more in the treatment group, that is in fact important for comfort during vaginal penetration.
The
FSFI is a brief, multidimensional scale for assessing FSD.
21 used a score of 23 out of 36 as the cut-off for diagnosed SD in
FSFI and we used 26.
The
FSFI was the body which ratified women's world records and one of the earliest was a time of 51.
The
FSFI is a validated self-administered questionnaire that consists of 19 questions and measures six domains of sexual function: desire, arousal, lubrication, orgasm, satisfaction and pain (8).
The primary outcome of the study was
FSFI total and subscale scores in patient group in comparison to control group.
Twenty-six participants completed a follow-up
FSFI, with a mean (SD) baseline score of 11.
At the beginning of the study, all of the women's
FSFI scores revealed that the women were struggling with FSD, with average scores of 13.
In the third study, there was statistically significant improvement in the change in sexual desire using the
FSFI Desire domain with flibanserin compared with placebo.
They also found significant negative correlation between total
FSFI score and age, partner age and marriage duration (18).
HAM-D and
FSFI (Female Sexual Function Index) scales were applied.
In a study of 72 women with vulvar disease and 72 controls who completed the Female Sexual Function Index (
FSFI) assessment, the median
FSFI score was 21.
